Management of Endometrial Cancer: French Society of Onco-Gynecology's Evaluation through a Delphi Survey

• Published in: Journal of clinical medicine 2022-11, Vol.11 (22)
• Main Authors: Marti, Carolin, Deluche, Elise, Jochum, Floriane, Bendifallah, Sofiane, Azais, Henri, Deidier, Jonas, Cockenpot, Vincent, Menoux, Inès, Balaya, Vincent, Betrian, Sarah, Chargari, Cyrus, Gouy, Sébastien, Genestie, Catherine, Feki, Anis, Uzan, Catherine, Guyon, Frederic, Devouassoux-Shisheboran, Mojgan, Body, Noémie, Akladios, Cherif, Mathevet, Patrice, Guani, Benedetta, On Behalf Of The Sfog And The Sfog Campus
• Format: Article
• Language: English
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm11226765

Our aim was to assess the opinion of a panel of experts and obtain a consensus on the management of endometrial cancer in France and French Switzerland. A Delphi survey was carried out among a panel of French and French-speaking Swiss experts. The first questionnaire included 65 questions divided into eight categories: characterization of experts, histo-molecular characteristics and radiological data of endometrial cancer, and management of low-risk, intermediate-risk, intermediate-high-risk, high-risk, and metastatic cancers. The experts were asked to reply on a 9-point scale, both on the validity and the clarity of each question. After the answers were analyzed, a second questionnaire was sent to the same experts. The study took place between December 2021 and March 2022. Further, 58 (57.4%) of the 101 experts responded in the first round, and 39 recommendations were obtained (60%). Six questions were voted redundant and 20 discordant. These questions were reformulated, and, at the end of the second round, 17 recommendations were validated (85%). In total, the study presents an analysis of 56 questions and related responses. Expert advice helps to clarify non-consensual issues, standardize the management of endometrial cancer, and optimize clinical practices.